Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
Stock data | 2023 | Change |
---|---|---|
Price | $6.67 | N/A |
Market Cap | $2.55B | N/A |
Shares Outstanding | 382.08M | 0.00% |
Employees | 4.50K | N/A |
Shareholder Equity | 9.73B | 9.18% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 2.70 | N/A |
P/S Ratio | 1.54 | N/A |
P/B Ratio | 0.26 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0095 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $1.65B | N/A |
Earnings | $92.47M | N/A |
EPS | 2.47 | N/A |
Earnings Yield | 0.3703 | N/A |
Gross Margin | 0.3764 | N/A |
Operating Margin | 0.1106 | N/A |
Net income margin | 0.056 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $2.90B | N/A |
Total Debt | $653.18M | N/A |
Cash on Hand | $320.32M | N/A |
Debt to Equity | 0.2000 | 4.70% |
Cash to Debt | 0.4904 | -9.00% |
Current Ratio | $1.13 | 1.51% |